SEEBRI

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug SEEBRI contains one active pharmaceutical ingredient (API):

1 Glycopyrronium bromide UNII V92SO9WP2I - GLYCOPYRROLATE

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. Read about Glycopyrronium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BB06		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10059K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526515030080802, 526516120087902
Country: CA	Health Products and Food Branch	Identifier(s): 02394936
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H5590613
Country: EE	Ravimiamet	Identifier(s): 1595932, 1595943, 1595954, 1595965, 1595976, 1595987, 1718489
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 12778003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 426318, 453556
Country: FR	Base de données publique des médicaments	Identifier(s): 69941269
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 214955, 315513, 375933, 379964
Country: HK	Department of Health Drug Office	Identifier(s): 62328
Country: IE	Health Products Regulatory Authority	Identifier(s): 30804
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7119
Country: IT	Agenzia del Farmaco	Identifier(s): 042306011, 042306023, 042306035, 042306047, 042306050, 042306062, 042306074, 042306086
Country: JP	医薬品医療機器総合機構	Identifier(s): 2259712G1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067946, 1067947, 1067948, 1067949, 1067950, 1067951, 1076818, 1076819
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 103M2013
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 103942
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15874
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100283667
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64726001, W64726002, W64726003, W64726004, W64726005, W64726006
Country: SG	Health Sciences Authority	Identifier(s): 14431P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 20833051
Country: ZA	Health Products Regulatory Authority	Identifier(s): 46/10.2.1/0840